title: Effect of eradication of Helicobacter pylori on the benign gastric ulcer recurrence--a 24 month follow-up study.
abstract: OBJECTIVE
  To evaluate the effect of eradication of Helicobacter pylori (H. pylori) on the recurrence of benign gastric ulcer (BGU) in the patients with BGU.
  
  
  METHODS
  This study was performed for 40 H. pylori-positive BGU patients cured of BGU and H. pylori eradicated, and for 25 H. pylori-positive patients (non-eradicated group) who were not treated with H. pylori eradication regimen or H. pylori was not eradicated. Four different methods--CLOtest, microscopy of Gram stained mucosal smear, culture and histology of modified Giemsa staining--were taken for identifying colonization of H. pylori before treatment, and 4 weeks after completion of triple therapy. For the control group in which triple therapy was not tried, follow-up gastroscopy was done to confirm the healing of the ulcer. To detect BGU recurrence, the gastroscopy was performed at 6, 12, 18, and 24 months after therapy.
  
  
  RESULTS
  In the non-eradicated group, the BGU recurrence rate was 16% within 6 months, 40% within 1 year, 56% within 18 months and 60% within 2 years. The respective recurrence rates in the 40 patients in whom the bacteria had been eradicated were 0%, 7.5%, 10% and 10% (4 patients), respectively. Among the four BGU-recurred patients in whom H. pylori had been eradicated, one patient was found to have BGU recurring with H. pylori positive again in one year, and another two patients had NSAIDs ingestion history.
  
  
  CONCLUSIONS
  The eradication of H. pylori in patients with BGU reduces the recurrence of BGU. In addition, the major causes of BGU recurrence look like NSAIDs ingestion and reinfection of H. pylori.
authors.affiliation: Department of Internal Medicine, Kangnam General Hospital, Public Corporation, Seoul, Korea.
authors.forename: N
authors.initials: N
authors.lastname: Kim
authors.forename: J H
authors.initials: JH
authors.lastname: Oh
authors.forename: C G
authors.initials: CG
authors.lastname: Lee
authors.forename: C
authors.initials: C
authors.lastname: Lim
authors.forename: K H
authors.initials: KH
authors.lastname: Won
authors.forename: W R
authors.initials: WR
authors.lastname: Choi
authors.forename: S H
authors.initials: SH
authors.lastname: Lee
authors.forename: S H
authors.initials: SH
authors.lastname: Lim
authors.forename: K H
authors.initials: KH
authors.lastname: Lee
mesh_terms: D000328:Adult; D000368:Aged; D000900:Anti-Bacterial Agents; D004359:Drug Therapy, Combination / Q000627:therapeutic use; D005260:Female; D005500:Follow-Up Studies; D016481:Helicobacter Infections / Q000150:complications* / Q000188:drug therapy; D016480:Helicobacter pylori; D006801:Humans; D008297:Male; D008875:Middle Aged; D012008:Recurrence; D013276:Stomach Ulcer / Q000209:etiology*; D013997:Time Factors
chemical_list: D000900:Anti-Bacterial Agents